The study will compare NHS and social data to track long term impact of childhood blood disorders.
A single one-time gene therapy could free patients with α-thalassemia, a rare and debilitating blood disorder, from the burden of lifelong transfusions. A single one-time gene therapy could free ...
WASHINGTON — The Food and Drug Administration has approved the first drug treatment for pediatric patients 12 and older with a rare blood disorder. The treatment for acquired thrombotic ...
Our inbox has been flooded with emails from viewers and readers who want to share their personal stories — people who want to ...
Novo Nordisk said it would take over a drug under development to treat rare blood and kidney disorders from Nasdaq-listed biopharmaceutical firm Omeros for up to $2.1 billion. Under the asset purchase ...
Are autoimmune diseases fatal? Normally, your immune system fights off disease and protects your body from infection. However, when you have an autoimmune disease, your immune system ...
PharmaEssentia will spend $46 million to build a new manufacturing facility in Puerto Rico. The move forms part of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results